Pfizer Inc. (LON:0Q1N)

London flag London · Delayed Price · Currency is GBP · Price in USD
23.44
+0.02 (0.10%)
At close: Aug 1, 2025
0.10%
Market Cap100.13B
Revenue (ttm)48.25B
Net Income (ttm)6.09B
Shares Outn/a
EPS (ttm)1.07
PE Ratio16.44
Forward PE8.30
Dividend1.31 (5.61%)
Ex-Dividend DateJul 25, 2025
Volume46,268
Average Volume53,023
Open23.29
Previous Close23.42
Day's Range23.08 - 23.51
52-Week Range20.77 - 31.30
Beta0.50
RSI32.88
Earnings DateAug 5, 2025

About Accolade

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Q1N
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial Statements

News

There is no news available yet.